Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for MariMed Inc. (MRMD : OTC)
 
 • Company Description   
MariMed Inc. is a multi-state cannabis operator. The Company develops, owns and manages seed to sale state-licensed cannabis facilities, which are models in horticultural principles, cannabis cultivation, cannabis-infused products and dispensary operations. Its products and brands, includes Betty's Eddies(R), Nature's Heritage(TM), Bourne Baking Co. and K-Fusion(R). MariMed Inc. is based in NORWOOD, Mass.

Number of Employees: 326

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.63 Daily Weekly Monthly
20 Day Moving Average: 517,180 shares
Shares Outstanding: 338.14 (millions)
Market Capitalization: $212.25 (millions)
Beta: 3.27
52 Week High: $1.20
52 Week Low: $0.55
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -12.82% -4.86%
12 Week -20.12% -15.90%
Year To Date -27.43% -15.41%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
10 Oceana Way
-
Norwood,MA 02062
USA
ph: 617-795-5140
fax: -
ir@mattio.com http://www.marimedinc.com
 
 • General Corporate Information   
Officers
Robert Fireman - Chief Executive Officer;Chairman and President
Jon R. Levine - Chief Financial Officer; Treasurer; Secretary; and
Eva Selhub - Director
David Allen - Director
Edward Gildea - Director

Peer Information
MariMed Inc. (BJCT)
MariMed Inc. (CADMQ)
MariMed Inc. (APNO)
MariMed Inc. (UPDC)
MariMed Inc. (IMTIQ)
MariMed Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 56782V107
SIC: 2833
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/15/22
Share - Related Items
Shares Outstanding: 338.14
Most Recent Split Date: (:1)
Beta: 3.27
Market Capitalization: $212.25 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.01 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.05 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/15/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 12.55
Trailing 12 Months: 31.39
PEG Ratio: -
Price Ratios
Price/Book: 4.84
Price/Cash Flow: 8.39
Price / Sales: 1.66
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 150.00%
Sales Growth
vs. Year Ago Period: 26.94%
vs. Previous Quarter: 0.77%
ROE
03/31/22 - 20.87
12/31/21 - 26.74
09/30/21 - 87.05
ROA
03/31/22 - 6.07
12/31/21 - 6.84
09/30/21 - 18.61
Current Ratio
03/31/22 - 1.59
12/31/21 - 1.64
09/30/21 - 2.22
Quick Ratio
03/31/22 - 1.23
12/31/21 - 1.28
09/30/21 - 1.73
Operating Margin
03/31/22 - 5.70
12/31/21 - 6.11
09/30/21 - 16.28
Net Margin
03/31/22 - 5.70
12/31/21 - 6.04
09/30/21 - 16.12
Pre-Tax Margin
03/31/22 - 20.45
12/31/21 - 19.61
09/30/21 - 26.46
Book Value
03/31/22 - 0.13
12/31/21 - 0.11
09/30/21 - 0.11
Inventory Turnover
03/31/22 - 5.50
12/31/21 - 5.90
09/30/21 - 5.61
Debt-to-Equity
03/31/22 - 0.39
12/31/21 - 0.48
09/30/21 - 0.51
Debt-to-Capital
03/31/22 - 42.16
12/31/21 - 32.26
09/30/21 - 33.68
 

Powered by Zacks Investment Research ©